HTRA4 and cancer: These results were confirmed by showing that downregulation of HtrA4 in the lung and breast cancer cells contributed to increased survival (Figure 3B and Figure 5B, Table 2), clonogenic potential (Figure 6B), and motility of cancer cells (Figure 7B).